February 23, 2024
Loading...
You are here:  Home  >  Health Care & Life Science  >  Current Article

Amgen sued for allegedly concealing $10B tax bill from investors 

IN THIS ARTICLE

Amgen headquarters in Thousand Oaks. (Courtesy photo) Thousand Oaks-based biotech giant Amgen is being sued for allegedly failing to quickly disclose to investors it might owe the Internal Revenue Service more than $10 billion in back taxes and penalties. The class action lawsuit was brought by Detroit-based Roofers Local No. 149 Pension Fund and filed…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.